Oric Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
I'm ready. Let's get started. Welcome everyone to the 42nd Annual J.P. Morgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at J.P. Morgan. I'm joined by my squad, Priyanka Grover, [Loreal Hall], Malcolm Kuno. Our next presenting company is Oric and presenting on behalf of the company is Jacob Chacko.
All right. Thanks for having us, Anupam. So just a quick reminder, I will be making some forward-looking statements during the course of this presentation.
So starting on slide 3, I'd like to -- it's my privilege today to tell you about Oric Pharmaceuticals. So Oric stands for overcoming resistance in cancer. In a nutshell, that encompasses the mission of the company and the pipeline that we have assembled. We're really excited because we think we've put together one of the most exciting pipelines in small-cap oncology today.
I will spend most of my time today talking to you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
